Oramed Pharmaceuticals
ORMP
#8876
Rank
S$0.11 B
Marketcap
$2.90
Share price
-2.69%
Change (1 day)
5.39%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): S$33.72 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of S$9.53 Million, an increase over its 2022 earnings that were of -S$49.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$33.72 M253.68%
2023 S$9.53 M-119.45%
2022 -S$49.02 Million39.17%
2021 -S$35.23 Million73.93%
2020 -S$20.26 Million18.53%
2019 -S$17.09 Million-16.62%
2018 -S$20.5 Million38.32%
2017 -S$14.82 Million12.51%
2016 -S$13.17 Million25.01%
2015 -S$10.54 Million18.18%
2014 -S$8.92 Million39.72%
2013 -S$6.38 Million46.4%
2012 -S$4.36 Million128.32%
2011 -S$1.91 Million-51.47%
2010 -S$3.94 Million35.21%
2009 -S$2.91 Million
2007 -S$4.58 Million607.04%
2006 -S$0.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.7 Billion-2,157.69%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.55 B 66,581.97%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
S$9.91 B 29,210.12%๐Ÿ‡ซ๐Ÿ‡ท France
-S$0.69 Million-102.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-S$0.28 Billion-899.66%๐Ÿ‡บ๐Ÿ‡ธ USA